The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 13, 2026

Filed:

Dec. 16, 2020
Applicants:

Standigm Inc., Seoul, KR;

Ajou University Industry-academic Cooperation Foundation, Suwon-si, KR;

Inventors:

Sang Myun Park, Suwon-si, KR;

Yu Ree Choi, Suwon-si, KR;

Jae Bong Kim, Suwon-si, KR;

Soo Jin Park, Suwon-si, KR;

Min Young So, Seoul, KR;

Hee Jung Koo, Seoul, KR;

Jin Han Kim, Seoul, KR;

Sang Ok Song, Seoul, KR;

So Jeong Yun, Seoul, KR;

Soo Jeong Kim, Seoul, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/536 (2006.01); A61K 9/00 (2006.01); A61P 25/16 (2006.01);
U.S. Cl.
CPC ...
A61K 31/536 (2013.01); A61K 9/0019 (2013.01); A61K 9/0053 (2013.01); A61P 25/16 (2018.01);
Abstract

A composition for preventing or treating synucleinopathies, which includes efavirenz or a salt or solvate thereof and a pharmaceutically acceptable carrier, is provided. The composition is useful in preventing or treating synucleinopathies, such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, because the composition serves to hinder cell-to-cell transmission of alpha-synuclein, prevent intracellular aggregation of α-synuclein, and inhibit transmission of aggregated α-synuclein.


Find Patent Forward Citations

Loading…